跳至主要内容
临床试验/NCT02629003
NCT02629003已完成1 期

Evaluation of Radiation Dose for [11C]Cimbi-36

Gitte Moos Knudsen1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
8
试验地点
1
主要终点
Effective dose and absorbed dose for selected organs

研究概览

简要总结

The purpose of this study is to determine the dosimetry for the Positron Emission Tomography (PET) tracer [11C]Cimbi-36 in two different Carbon-11 labelling positions. This information will contribute to determining whether [11C]Cimbi-36 can be optimized by changing the C-11 labelling position.

详细描述

Healthy subjects wil undergo a whole-body Positron Emission Tomography (PET) scan with the Serotonin 2A Receptor (5-HT2A) radioligand [11C]Cimbi-36 or [11C]Cimbi-36-5 to determine the effective radiation dose and radiation dose for selected organs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age
  • Signed informed consent

排除标准

  • Present or former neurological disease, severe somatic or psychiatric disease, or medication thet can interfere with the test results.
  • Pregnancy at the time of the scan
  • Breastfeeding
  • Alcohol or substance abuse
  • Exposure to radiation (>10 millisievert (mSv)) within the last year, or significant exposure at work
  • Allergy to any of the substances in the Investigational medicinal product (IMP) formulation

研究组 & 干预措施

[11C]Cimbi-36

Active Comparator

[11C]Cimbi-36

Maximum of 600 Mega Becquerel (MBq) or 1.5 micrograms, single dose intravenous (I.V.)

干预措施: [11C]Cimbi-36 (Drug)

[11C]Cimbi-36-5

Active Comparator

[11C]Cimbi-36-5

Maximum of 600 Mega Becquerel (MBq) or 1.5 micrograms, single dose intravenous (I.V.)

干预措施: [11C]Cimbi-36-5 (Drug)

结局指标

主要结局

Effective dose and absorbed dose for selected organs

时间窗: 0 - 120 minutes

Based on the Positron Emission Tomography (PET) scan Time activity curves (TACs) will be generated and used for calculating the radiation doses for selected organs and over all effective radiation dose.

次要结局

  • Measurement of radioactive metabolites in plasma(0 - 120 minutes)
  • Measurement of radioactivity in plasma and whole blood(0 - 120 minutes)

研究者

发起方
Gitte Moos Knudsen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Gitte Moos Knudsen

Chair, Professor, MD, DMSc

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验

[11C]Cimbi-36 Dosimetry | 临床试验